CORD-19:038354e8830fe01feb621a12e8a8c467a15b6354 / 167975-168115 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T1050","span":{"begin":0,"end":140},"obj":"Sentence"},{"id":"T40212","span":{"begin":0,"end":140},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Two specific inhibitors of influenza A and B neuraminidase are currently available for clinical use: inhaled zanamivir and oral oseltamivir."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T118","span":{"begin":0,"end":140},"obj":"Sentence"}],"text":"Two specific inhibitors of influenza A and B neuraminidase are currently available for clinical use: inhaled zanamivir and oral oseltamivir."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T888","span":{"begin":27,"end":36},"obj":"Disease"}],"attributes":[{"id":"A888","pred":"mondo_id","subj":"T888","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"}],"text":"Two specific inhibitors of influenza A and B neuraminidase are currently available for clinical use: inhaled zanamivir and oral oseltamivir."}